BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 9184718)

  • 1. Automated peritoneal dialysis: new implications for pharmacists.
    Brophy DF; Mueller BA
    Ann Pharmacother; 1997 Jun; 31(6):756-64. PubMed ID: 9184718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exfoliated mesothelial cell and CA-125 in automated peritoneal dialysis (APD) and continuous ambulatory peritoneal dialysis (CAPD) patients.
    Kanjanabuch T; Puttipittayathorn N; Leelahavanichkul A; Lieusuwan S; Katavetin P; Mahatanan N; Sriudom K; Chirananthavat T; Thongbor N; Eiam-Ong S
    J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S119-25. PubMed ID: 22043578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous ambulatory peritoneal dialysis versus automated peritoneal dialysis for end-stage renal disease.
    Rabindranath KS; Adams J; Ali TZ; MacLeod AM; Vale L; Cody J; Wallace SA; Daly C
    Cochrane Database Syst Rev; 2007 Apr; 2007(2):CD006515. PubMed ID: 17443624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of culture-directed antibiotics for the treatment of peritonitis in automated peritoneal dialysis: A systematic narrative review.
    Ling CW; Sud K; Van C; Zaidi STR; Patel RP; Peterson GM; Castelino RL
    Perit Dial Int; 2021 May; 41(3):261-272. PubMed ID: 33559525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residual renal function in children treated with continuous ambulatory peritoneal dialysis or automated peritoneal dialysis--a preliminary study.
    Roszkowska-Blaim M; Skrzypczyk P; Drozdz D; Pietrzyk JA
    Adv Perit Dial; 2009; 25():103-9. PubMed ID: 19886329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous ambulatory peritoneal dialysis and automated peritoneal dialysis: are there differences in outcome?
    Dell'Aquila R; Berlingò G; Pellanda MV; Contestabile A
    Contrib Nephrol; 2009; 163():292-299. PubMed ID: 19494628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin in peritoneal dialysis: Clinical pharmacology considerations in therapy.
    Lam E; Lien YTK; Kraft WK; Piraino B; Vozmediano V; Schmidt S; Zhang J
    Perit Dial Int; 2020 Jul; 40(4):384-393. PubMed ID: 32065053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superior survival of high transporters treated with automated versus continuous ambulatory peritoneal dialysis.
    Johnson DW; Hawley CM; McDonald SP; Brown FG; Rosman JB; Wiggins KJ; Bannister KM; Badve SV
    Nephrol Dial Transplant; 2010 Jun; 25(6):1973-9. PubMed ID: 20097847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of peritoneal dialysis method on residual renal function in children.
    Roszkowska-Blaim M; Skrzypczyk P; Jander A; Tkaczyk M; Bałasz-Chmielewska I; Zurowska A; Drozdz D; Pietrzyk JA
    Adv Perit Dial; 2012; 28():112-9. PubMed ID: 23311226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of lamivudine in subjects receiving peritoneal dialysis in end-stage renal failure.
    Asari A; Iles-Smith H; Chen YC; Naderer OJ; Johnson MA; Yuen GJ; Otto V; Dunn JA; Gokal R
    Br J Clin Pharmacol; 2007 Dec; 64(6):738-44. PubMed ID: 17662093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-Dwell Cycling Intraperitoneal Cefazolin Plus Ceftazidime in Peritoneal Dialysis Patients.
    Peerapornratana S; Chariyavilaskul P; Kanjanabuch T; Praditpornsilpa K; Eiam-Ong S; Katavetin P
    Perit Dial Int; 2017; 37(2):218-224. PubMed ID: 27738089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of peritonitis in APD: pharmacokinetic principles.
    Manley HJ; Bailie GR
    Semin Dial; 2002; 15(6):418-21. PubMed ID: 12437537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practical guidelines for automated peritoneal dialysis.
    Sritippayawan S; Nilwarangkur S; Aiyasanon N; Jattanawanich P; Vasuvattakul S
    J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S167-74. PubMed ID: 22043586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritonitis - does peritoneal dialysis modality make a difference?
    Piraino B; Sheth H
    Blood Purif; 2010; 29(2):145-9. PubMed ID: 20093820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of intraperitoneal cefepime in automated peritoneal dialysis.
    Elwell RJ; Frye RF; Bailie GR
    Perit Dial Int; 2005; 25(4):380-6. PubMed ID: 16022096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphate clearance in peritoneal dialysis: automated PD compared with continuous ambulatory PD.
    Sawin DA; Himmele R; Diaz-Buxo JA
    Adv Perit Dial; 2012; 28():120-5. PubMed ID: 23311227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing automated peritoneal dialysis with continuous ambulatory peritoneal dialysis: survival and quality of life differences?
    Balasubramanian G; McKitty K; Fan SL
    Nephrol Dial Transplant; 2011 May; 26(5):1702-8. PubMed ID: 20921296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrafiltration with icodextrins in continuous ambulatory peritoneal dialysis and automated peritoneal dialysis.
    Neri L; Viglino G; Cappelletti A; Gandolfo C; Cavalli PL
    Adv Perit Dial; 2000; 16():174-6. PubMed ID: 11045287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritonitis rates and common microorganisms in continuous ambulatory peritoneal dialysis and automated peritoneal dialysis.
    Akman S; Bakkaloglu SA; Ekim M; Sever L; Noyan A; Aksu N
    Pediatr Int; 2009 Apr; 51(2):246-9. PubMed ID: 19405925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Automated peritoneal dialysis--actual clinical aspects].
    Vychytil A
    Wien Klin Wochenschr; 2005; 117 Suppl 6():98-108. PubMed ID: 16437340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.